ES2037095T3 - Un procedimiento para preparar una composicion farmaceutica. - Google Patents

Un procedimiento para preparar una composicion farmaceutica.

Info

Publication number
ES2037095T3
ES2037095T3 ES198787310550T ES87310550T ES2037095T3 ES 2037095 T3 ES2037095 T3 ES 2037095T3 ES 198787310550 T ES198787310550 T ES 198787310550T ES 87310550 T ES87310550 T ES 87310550T ES 2037095 T3 ES2037095 T3 ES 2037095T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
pharmaceutical composition
interferon
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787310550T
Other languages
English (en)
Inventor
Martin Cole
Malcolm Richard Beecham Pharmaceuticals Boyd
David Beecham Pharmaceuticals Sutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2037095T3 publication Critical patent/ES2037095T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

PRODUCTO FARMACEUTICO QUE COMPRENDE UN INTERFERON Y UN COMPUESTO DE FORMULA (A), O UN PROMEDICAMENTO, O UNA SAL FARMACEUTICAMENTE ACEPTABLE, ESTER DE FOSFATO Y/O DERIVADO ACILICO DE AMBOS COMO UNA PREPARACION COMBINADA PARA USO SIMULTANEO, SEPARADO O SECUENCIAL EN TERAPIA ANTIVIRAL.
ES198787310550T 1986-12-02 1987-11-30 Un procedimiento para preparar una composicion farmaceutica. Expired - Lifetime ES2037095T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868628826A GB8628826D0 (en) 1986-12-02 1986-12-02 Pharmaceutical products

Publications (1)

Publication Number Publication Date
ES2037095T3 true ES2037095T3 (es) 1993-06-16

Family

ID=10608331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787310550T Expired - Lifetime ES2037095T3 (es) 1986-12-02 1987-11-30 Un procedimiento para preparar una composicion farmaceutica.

Country Status (16)

Country Link
US (1) US4957733A (es)
EP (1) EP0271270B1 (es)
JP (1) JP2724711B2 (es)
KR (1) KR960000432B1 (es)
AT (1) ATE74011T1 (es)
AU (1) AU606629B2 (es)
CA (1) CA1318850C (es)
DE (1) DE3777769D1 (es)
DK (1) DK166715B1 (es)
ES (1) ES2037095T3 (es)
GB (1) GB8628826D0 (es)
GR (1) GR3004487T3 (es)
IE (1) IE59943B1 (es)
NZ (1) NZ222741A (es)
PT (1) PT86232B (es)
ZA (1) ZA878983B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
DE69021791T2 (de) * 1989-06-30 1996-05-02 American Cyanamid Co Verwendung eines phagozytise-aktievierenden Stoffes : LPS oder IL-2 zur Herstellung eines Arzneimittels zur Behandlung von Staphylococcus-aureus-Infektionen bei Kühen.
JPH03124960A (ja) * 1989-10-11 1991-05-28 Mitsubishi Electric Corp 同軸形スタータ装置
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9615111D0 (en) * 1996-07-18 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
WO1998023285A1 (en) * 1996-11-29 1998-06-04 Smithkline Beecham Plc Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis b
US6165458A (en) * 1997-12-26 2000-12-26 Pharmaderm Laboratories Ltd. Composition and method for dermal and transdermal administration of a cytokine
EP1655813A1 (de) * 2004-11-09 2006-05-10 Phoenix Contact GmbH & Co. KG Befestigung für elektrische Verbindung
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition

Also Published As

Publication number Publication date
DK166715B1 (da) 1993-07-05
ZA878983B (en) 1988-08-31
NZ222741A (en) 1990-10-26
JPS63145279A (ja) 1988-06-17
AU606629B2 (en) 1991-02-14
KR960000432B1 (ko) 1996-01-06
JP2724711B2 (ja) 1998-03-09
PT86232B (pt) 1990-11-07
DK627987D0 (da) 1987-11-30
DK627987A (da) 1988-06-03
EP0271270B1 (en) 1992-03-25
IE873247L (en) 1988-06-02
EP0271270A2 (en) 1988-06-15
CA1318850C (en) 1993-06-08
DE3777769D1 (de) 1992-04-30
PT86232A (en) 1987-12-01
GR3004487T3 (es) 1993-03-31
IE59943B1 (en) 1994-05-04
US4957733A (en) 1990-09-18
KR880007080A (ko) 1988-08-26
AU8191287A (en) 1988-06-02
EP0271270A3 (en) 1989-09-27
ATE74011T1 (de) 1992-04-15
GB8628826D0 (en) 1987-01-07

Similar Documents

Publication Publication Date Title
IT8822399A0 (it) Derivati di monofosforil lipide a e procedimento per la loro preparazione.
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
HUT46657A (en) Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient
MX9201672A (es) Compuesto de pirazol piridina y procedimiento para la preparacion de los mismos.
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
HUT53522A (en) Process for producing pharmaceutical compositions comprising purine derivatives
AU581855B2 (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
AU5649286A (en) New derivatives of 4-phenylpropyl indole and their salts, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
IL97509A0 (en) Lipid lowering compositions comprising bambuterol
IT8740155A0 (it) Estensione dell'uso di un prodotto farmaceutico alimentare curativo
DE3374316D1 (en) Penicillin derivatives
HUT50807A (en) Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient
FI935388A0 (fi) Menetelmä lääkeaineena käyttökelpoisen bentsimidatsolidipyridiniumjohdannaisten valmistamiseksi
ES551388A0 (es) Procedimiento de preparacion de derivados 3,5-diamino-1h-1,2,4-triazoles y de sales de adicion acida farmaceuticamente aceptables de los mismos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271270

Country of ref document: ES